Breath gas metabolites and bacterial metagenomes from cystic fibrosis airways indicate active pH neutral 2,3-butanedione fermentation.
about
Airborne Bacterial Interactions: Functions Out of Thin Air?Role of bacterial volatile compounds in bacterial biologyEffects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during ExacerbationMicrobial, host and xenobiotic diversity in the cystic fibrosis sputum metabolomeEcological networking of cystic fibrosis lung infections.The upper respiratory tract as a microbial source for pulmonary infections in cystic fibrosis. Parallels from island biogeography.Stochastic tracking of infection in a CF lungSpecialized metabolites from the microbiome in health and disease.Impact of storage conditions on metabolite profiles of sputum samples from persons with cystic fibrosisCystic fibrosis lung microbiome: opportunities to reconsider management of airway infection.Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial interventionThe cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy.Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.A Winogradsky-based culture system shows an association between microbial fermentation and cystic fibrosis exacerbationMetabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease.The role for neutrophil extracellular traps in cystic fibrosis autoimmunity.Sniffing out the hypoxia volatile metabolic signature of Aspergillus fumigatus.How can the cystic fibrosis respiratory microbiome influence our clinical decision-making?A Different Microbiome Gene Repertoire in the Airways of Cystic Fibrosis Patients with Severe Lung Disease.Biomarkers for cystic fibrosis drug development.Acquisition and adaptation of the airway microbiota in the early life of cystic fibrosis patients.Differential responses of human dendritic cells to metabolites from the oral/airway microbiome.Metabolite transfer with the fermentation product 2,3-butanediol enhances virulence by Pseudomonas aeruginosa.Comparative analysis of the volatile metabolomes of Pseudomonas aeruginosa clinical isolates.The fermentation product 2,3-butanediol alters P. aeruginosa clearance, cytokine response and the lung microbiome.Strain- and Substrate-Dependent Redox Mediator and Electricity Production by Pseudomonas aeruginosa.Making It Last: Storage Time and Temperature Have Differential Impacts on Metabolite Profiles of Airway Samples from Cystic Fibrosis Patients.Vive la Persistence: Engineering Human Microbiomes in the 21st Century.Niche partitioning of a pathogenic microbiome driven by chemical gradientsInteraction between and in cystic fibrosis
P2860
Q26770681-20FB318B-36FB-4133-A999-EBB5130B9360Q28083831-94E2B8B5-4665-43EA-9D07-78B5960A9AF3Q28584597-47149BC9-2E8A-4CB6-ABA9-2734F676450BQ28829667-E5E9C267-F883-45CB-8BFA-EE59B7977531Q33767505-3C1773B6-EEFA-4332-BFA2-4F98207DCA8BQ33901596-D443183B-F4B6-4F0A-BC39-A00D44E7E039Q34434661-93DA7DEB-1960-4FE6-BB47-37D163B55105Q35111744-A3E847C4-C32D-4E9E-BBAC-09ECCE210D26Q35569460-C79A3D81-5DCE-4492-9916-CF771474516FQ35763672-4155EAFE-8A1E-4032-A2A1-61EF54B99EE9Q35837327-C554F42C-EACA-4DC9-8C59-DF0F2C87302EQ35861377-E14297D5-1476-4A22-B7B9-2F57EFF440C8Q36575038-4280F907-4861-423B-9ACC-77EAB8794CB0Q36756544-F0FFBF4A-5AED-447F-9B63-FE62F2D9E33BQ37191286-A0EF9EA2-2DC1-4438-B000-6C56DAF7CB06Q37351609-7BDD4898-E1B8-4306-BFE6-3DCCD25C9E12Q38616379-E2BB16E1-5814-4A3E-B058-60DBC904BF63Q38635041-34BE73FA-D038-4EB5-9DB5-3DFE62073A11Q38652042-78F53101-A1A2-4447-AAD7-45280F1A9B0BQ38755600-D5A0F95B-C610-4307-91C4-F019719B8C34Q38769187-3F3BE307-0E1F-4908-8668-66FCBB2633EAQ38962869-C088A5FA-9C34-40F7-AE71-876C63819677Q39853469-B343E767-6459-42CA-BC03-67E9DB08451BQ40442905-0D372347-77DB-42AB-B428-3CFC374F1961Q40675590-5EC56891-0266-4AF2-BA3F-9E4F1E877461Q42389870-9CF1B77A-C2CD-48DF-A166-1D6AF68274ADQ46311500-6F83A8B0-2D01-4E9D-A3D2-22129AD455C8Q54235445-26C98E6C-02D1-4713-AF25-FEC1E3B8B198Q58376391-FC1A13D0-A0C4-4988-9A18-FC76EEF509A0Q59137961-13671D34-7B18-4F1C-8D44-287726519872
P2860
Breath gas metabolites and bacterial metagenomes from cystic fibrosis airways indicate active pH neutral 2,3-butanedione fermentation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Breath gas metabolites and bac ...... 2,3-butanedione fermentation.
@ast
Breath gas metabolites and bac ...... 2,3-butanedione fermentation.
@en
type
label
Breath gas metabolites and bac ...... 2,3-butanedione fermentation.
@ast
Breath gas metabolites and bac ...... 2,3-butanedione fermentation.
@en
prefLabel
Breath gas metabolites and bac ...... 2,3-butanedione fermentation.
@ast
Breath gas metabolites and bac ...... 2,3-butanedione fermentation.
@en
P2093
P2860
P50
P356
P1433
P1476
Breath gas metabolites and bac ...... 2,3-butanedione fermentation.
@en
P2093
Douglas Conrad
Heather Maughan
Robert Quinn
Robert Schmieder
Simone Meinardi
Yan Wei Lim
P2860
P2888
P304
P356
10.1038/ISMEJ.2013.229
P577
2014-01-09T00:00:00Z
P5875
P6179
1040190874